Carregant...

The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma

BACKGROUND: Despite significant advances in the understanding of glioblastoma genetics and biology, survival is still poor. Hypoxia and nutrient depletion in the tumour microenvironment induce adaptive signalling and metabolic responses, which can influence sensitivity to therapeutic regimens. DNA d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Foltyn, Martha, Luger, Anna-Luisa, Lorenz, Nadja I., Sauer, Benedikt, Mittelbronn, Michel, Harter, Patrick N., Steinbach, Joachim P., Ronellenfitsch, Michael W.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461855/
https://ncbi.nlm.nih.gov/pubmed/30745581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0368-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!